Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-22-000679
Filing Date
2022-11-21
Accepted
2022-11-21 16:13:39
Documents
36
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 abti10q.htm   iXBRL 10-Q 550206
2 ex31_1.htm EX-31.1 9013
3 ex31_2.htm EX-31.2 9023
4 ex32_1.htm EX-32.1 5717
5 GRAPHIC image_001.jpg GRAPHIC 2736
  Complete submission text file 0001663577-22-000679.txt   2180458

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abti-20220930.xsd EX-101.SCH 15321
7 XBRL CALCULATION FILE abti-20220930_cal.xml EX-101.CAL 32955
8 XBRL DEFINITION FILE abti-20220930_def.xml EX-101.DEF 41047
9 XBRL LABEL FILE abti-20220930_lab.xml EX-101.LAB 145683
10 XBRL PRESENTATION FILE abti-20220930_pre.xml EX-101.PRE 119559
30 EXTRACTED XBRL INSTANCE DOCUMENT abti10q_htm.xml XML 188923
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-156091 | Film No.: 221405899
SIC: 2833 Medicinal Chemicals & Botanical Products